NEPA21 Cell Image Viability and Transfection Efficiency Results
NEPA21 Cell Image Viability and Transfection Efficiency Results
HeLaHuman Cervical Carcinoma cells |
|
|
. |
Viability: 95% |
Transfection Efficiency: 95% |
| . | |
293T (HEK293T)
|
|
![]() |
![]() |
Viability: 90% |
Transfection Efficiency: 90% |
| . | . |
TIG-7Human Embryonic Lung Fibroblasts |
|
. |
. |
Viability 89% |
Transfection Efficiency 76% |
| . | . |
MRC-5Human Embryonic Lung Fibroblasts |
|
![]() |
![]() |
Viability 85% |
Transfection Efficiency 90% |
| . | . |
SUSM-1Human Fibroblasts |
|
![]() |
![]() |
Viability 77% |
Transfection Efficiency 71% |
| . | . |
KMST-6Human Fibroblasts |
|
![]() |
![]() |
Viability 70% |
Transfection Efficiency 60% |
| . | . |
HT1080Human Fibrosarcoma cells |
|
![]() |
![]() |
Viability 93% |
Transfection Efficiency 81% |
| . | . |
MIA-PaCa-2Human Pancreatic Carcinoma cells |
|
![]() |
![]() |
Viability 80% |
Transfection Efficiency 77% |
| .. | . |
HepG2Human Hepatoma cells |
|
![]() |
![]() |
Viability 88% |
Transfection Efficiency 76% |
| . |
. |
HuH-7Human Hepatoma cells |
|
![]() |
![]() |
Viability: 70% |
Transfection Efficiency: Good |
| . | |
HSC-2Human Squamous Carcinoma cells |
|
![]() |
![]() |
Viability: 90-95% |
Transfection Efficiency: 98% |
| . | |
HSC-3Human Squamous Carcinoma cells |
|
![]() |
![]() |
Viability: 90-95% |
Transfection Efficiency: 98% |
| . | |
HSC-4Human Squamous Carcinoma cells |
|
![]() |
![]() |
Viability: 80% |
Transfection Efficiency: 31% |
| . | |
Ca9-22Human Squamous Carcinoma cells |
|
![]() |
![]() |
Viability: 60% |
Transfection Efficiency: 60% |
| . | |
HGFHuman Gingival Fibroblasts |
|
![]() |
![]() |
Viability: Good |
Transfection Efficiency: Good |
| . | |
MCF-10AHuman Breast Cells |
|
![]() |
![]() |
Viability: Good |
Transfection Efficiency: Good |
| . | |
TE-1Human Esophageal Carcinoma cells |
|
![]() |
![]() |
Viability 85% |
Transfection Efficiency 41% |
| . | . |
TE-8Human Esophageal Carcinoma cells |
|
![]() |
![]() |
Viability 85% |
Transfection Efficiency 40% |
| . | |
SKOV-3Human Ovarian Carcinoma cells |
|
![]() |
![]() |
Viability: 90% |
Transfection Efficiency: 90% |
| . | . |
OVCAR-3Human Ovarian Carcinoma cells |
|
![]() |
![]() |
Viability 90% |
Transfection Efficiency 79% |
| . | . |
RMG-1Human Ovarian Clear Cell Adenocarcinoma |
|
![]() |
![]() |
Viability 97% |
Transfection Efficiency 67% |
| . | . |
SK-N-SHHuman Neuroblastoma cells |
|
![]() |
![]() |
| Blue: TO-PRO Green: GFP | |
Viability 95% |
Transfection Efficiency 95% |
| . | |
SH-SY5YHuman Neuroblastoma cells |
|
*Left image: Lipofectamine LTX [ Viability:90% Transfection Efficiency:10%] |
![]() |
Viability: 60% |
Transfection Efficiency: 90% |
| . | |
| . | |
KG-1-CHuman Oligodendroglial cells |
|
![]() |
![]() |
Viability 85% |
Transfection Efficiency 60% |
| . | |
A172Human Glioblastoma cells |
|
![]() |
![]() |
Viability: 80-90% |
Transfection Efficiency: 70% |
| . | . |
1321N1Human Astrocytoma cells |
|
![]() |
![]() |
Viability: 80% |
Transfection Efficiency: 80% |
| . | |
HaCaTHuman Keratinocyte cells |
|
![]() |
![]() |
Viability 40% |
Transfection Efficiency 80% |
| . | . |
CCD1079skHuman Skin Fibroblasts |
|
![]() |
![]() |
Viability 40% |
Transfection Efficiency 53% |
| . | . |
HTR-8/SvneoHuman Trophoblast cells |
|
![]() |
![]() |
Viability 95% |
Transfection Efficiency 67% |
| . | . |
JurkatHuman T-cell Leukemia cells |
|
![]() |
![]() |
Viability: 90% |
Transfection Efficiency: 85% |
| . | |
MutuHuman Burkitt Lymphoma cells |
|
![]() |
![]() |
Viability: 87% |
Transfection Efficiency: 91% |
| . | . |
LCLHuman Lymphoblastoid cell |
|
![]() |
![]() |
Viability: 41% |
Transfection Efficiency: 40% |
| . | |
Ramos-BlueTMHuman Burkitt Lymphoma cells |
|
![]() |
![]() |
Viability: 80% |
Transfection Efficiency: 55% |
| . | |
K562Human Erythroleukemia cells |
|
![]() |
![]() |
Viability: 91% |
Transfection Efficiency: 99% |
| . | |
THP-1Human acute monocytic leukemia cells |
|
![]() |
![]() |
Viability: 76% |
Transfection Efficiency: 63% |
| . | |
NIH/3T3Mouse Embryonic Fibroblasts |
|
![]() |
![]() |
Viability: 74% |
Transfection Efficiency: 82% |
| . | |
3T3-L1Mouse Preadipocytes |
|
![]() |
![]() |
Viability: 90% |
Transfection Efficiency: 90% |
| . | |
MEFMouse Embryonic Fibroblasts |
|
![]() |
![]() |
Viability: 95% |
Transfection Efficiency: 65% |
| . | |
LMouse Fibroblasts |
|
![]() |
![]() |
Viability: 90% |
Transfection Efficiency: 65% |
| . | |
MC3T3-E1Mouse Osteoblastic cells |
|
![]() |
![]() |
Viability 85% |
Transfection Efficiency 75% |
| . | . |
LLc1 (LL/2)Mouse Lewis lung cell carcinoma 1 cells |
|
![]() |
![]() |
Viability: 87% |
Transfection Efficiency: 81% |
| . | |
C2C12Mouse Myoblast cells |
|
![]() |
|
Viability: 80% |
Transfection Efficiency: 70% |
| . | |
4T1Mouse Breast Cancer cells |
|
![]() |
![]() |
Viability: 90% |
Transfection Efficiency: 95% |
| . | |
Colon-26Mouse Colon Adenocarcinoma cells |
|
![]() |
|
Viability: 95% |
Transfection Efficiency: 90% |
| . | |
ddy Mouse Endometrial cells |
|
![]() |
![]() |
Viability: 60% |
Transfection Efficiency: 80% |
| . | |
WR19LMouse T-cell lymphoma cells |
|
![]() |
![]() |
Viability: 92% |
Transfection Efficiency: 60% |
| . | |
RAW264.7Mouse Macrophage-like cells |
|
![]() |
![]() |
Viability: 70% |
Transfection Efficiency: 56% |
| . | |
MIN6Mouse Pancreatic Beta cells |
|
![]() |
![]() |
Viability 57% |
Transfection Efficiency 71% |
| . | |
Mouse Pancreatic Islet Beta cells |
|
![]() |
![]() |
Viability: 60% |
Transfection Efficiency: 40% |
| . | |
XS106Mouse Dendritic Cells |
|
![]() |
|
Viability 61% |
Transfection Efficiency 45% |
| . | . |
MC/9Mouse Mast cells |
|
![]() |
![]() |
Viability: 76% |
Transfection Efficiency: 84% |
| . | |
BMBaMouse Bone marrow-derived basophils |
|
![]() |
|
Viability: 45% |
Transfection Efficiency: 67% |
| . | |
TSMouse Trophoblast Stem cells |
|
![]() |
![]() |
Viability 59% |
Transfection Efficiency 47% |
| . | |
ATDC5Mouse Pre-chondrocytic cells |
|
![]() |
![]() |
Blue:DAPI Green:GFP For ref. invitrogen:Lipofectamine LTX (with Plus Reagent) Transfection Efficiency:0.001% |
|
Viability: 62% |
Transfection Efficiency: 14% |
| . | |
PC12Rat Adrenal Pheochromocytoma cells |
|
![]() |
|
Viability: 70% |
Transfection Efficiency: 50% |
| . | |
H9c2Rat Ventricular Myoblasts |
|
![]() |
![]() |
Viability 71% |
Transfection Efficiency 82% |
| . | . |
REFRat Embryonic Fibroblasts |
|
![]() |
![]() |
Viability 90% |
Transfection Efficiency 99% |
| . | . |
C6Rat Glioma cells |
|
![]() |
![]() |
Viability 80% |
Transfection Efficiency 67% |
| . | . |
RSC96Rat Schwann cells |
|
![]() |
![]() |
Viability: 70% |
Transfection Efficiency: 85% |
| . | |
TtT/GFRat Anterior Pituitary cells |
|
![]() |
![]() |
Viability: 65% |
Transfection Efficiency: 83% |
| . | |
CHOChinese Hamster Ovary cells |
|
![]() |
![]() |
Viability 74% |
Transfection Efficiency 90% |
| . | . |
CHO-K1Chinese Hamster Ovary cells |
|
![]() |
![]() |
Viability 95% |
Transfection Efficiecncy 95% |
| . | . |
DT40Chicken B cells |
|
![]() |
![]() |
Viability 38% |
Transfection Efficiency 40% |
| . | . |
MDCKMadrin-Darby Canine |
|
![]() |
![]() |
Viability: 90% |
Transfection Efficiency: 95% |
| . | |
GTS9Ginbuna Thymus cells |
|
![]() |
![]() |
Viability 50% |
Transfection Efficiency 30% |
| . | . |
Mouse TT2 ES cells |
|
![]() |
![]() |
Viability: 55% |
Transfection Efficiency: 55% |
| . | |
Mouse iPS cells |
|
![]() |
![]() |
Viability: 89% |
Transfection Efficiency: 47% |
Primary HASMHuman Airway Smooth Muscle cells |
|
![]() |
![]() |
Viability 90% |
Transfection Efficiency 80% |
| . | . |
PrimaryHuman Endometrial Stromal Cells |
|
![]() |
![]() |
Viability 95% |
Transfection Efficiency 90% |
| . | . |
PrimaryHuman Uterine Cervical Fibroblast |
|
![]() |
![]() |
Viability 65% |
Transfection Efficiency 90% |
| . | . |
PrimaryHuman T cells |
|
![]() |
![]() |
The cells were cultured and stimulated with CD3 CD28 antibody for 66 hours before Electroporation(the result of amaxa’s device: V about 20% TE about 60%) |
|
Viability: 58% |
Transfection Efficiency: 90% |
PrimaryMouse Cerebral Cortex Neurons |
|
![]() |
![]() |
9 days after EPRed: MAP2 Blue: GFAP Green: GFP The cells were from Embryonic Day 14 Mouse Cerebral Cortex |
|
Viability 80% |
Transfection Efficiency 70% |
| . | . |
PrimaryMouse Neural Stem cells |
|
![]() |
![]() |
Viability: Good |
Transfection Efficiency: 37% |
PrimaryMouse Microglia cells |
|
![]() |
![]() |
Viability 65% |
Transfection Efficiency 23% |
| . | . |
Primary MEFMouse Embryonic Fibroblasts |
|
![]() |
![]() |
Viability: 90% |
Transfection Efficiency: 85% |
| . | |
PrimaryMouse Embryonic Skin Fibroblasts |
|
![]() |
![]() |
Viability: 90% |
Transfection Efficiency: 50% |
Primary BMMCMouse Bone Marrow-Derived Mast Cells |
|
![]() |
![]() |
Viability 64% |
Transfection Efficiency 78% |
| . | . |
PrimaryRat Bulbar Neurons |
|
|
![]() |
7 days after EP / The cells were from Embryonic Day 15 Rat Bubblar Neurons |
|
Viability 80% |
Transfection Efficiency 75% |
| . | |
PrimaryRat Meningeal Fibroblasts |
|
![]() |
|
Viability: 90% |
Transfection Efficiency: 95% |
| . | . |
PrimaryRat Meningeal Fibroblasts |
|
![]() |
![]() |
Viability 90% |
Transfection Efficiency 95% |
| . | . |
PrimaryRat Meningeal Fibroblasts |
|
|
![]() |
| Blue: NG2 Green: GFP Postnatal day 3 | |
Viability: 90% |
Transfection Efficiency: 95% |
| . | |
Primary OECRat Olfactory Ensheathing Cells |
|
![]() |
![]() |
5 days after electroporation / The cells were from Postnatal Week 3 / Electroporation: after being cultured for 2 weeks. |
|
Viability 93% |
Transfection Efficiency 46% |
| . | . |
PrimaryChick Embryonic Cerebellar Granule Cells |
|
![]() |
![]() |
| *Explant Culture (cell clusters) Embryonic day 13, **Scale: 50 µm | |
Viability: |
Transfection Efficiency: 35% |
| . | |
3T3-L1 Mouse PreadipocytesIn Adherence |
|
![]() |
![]() |
Viability: 90% |
Transfection Efficiency: 70% |
24 hours after electroporationElectroporation: After 7 days of differentiation |
![]() ![]() |
| NEPA21 Adherent Cell EP with CU600…….. CUY900-13-3-5 – Electrode holder and CUY900-13-3-5 Electrode ……….for Adherent Cell EP |
|
| . | |
SH-SY5YHuman Neuroblastoma cellsIn Adherence |
|
![]() |
![]() ![]() |
Viability: 90% |
Transfection Efficiency: 50% |
| . | |
C6 Rat Glioma cells
|
|
![]() |
![]() |
Viability: 80% |
Transfection Efficiency: 39% |
![]() ![]() |
|
| . | . |
Primary Mouse Neurons
|
|
![]() |
![]() |
| 2 days after electroporation The neurons were prepared from E15 mouse cerebral cortex. Electroporation: After 6 DIV (on 24-well plates) |
![]() |
Viability Good |
Transfection Efficiency Good |
| .. | |
Primary Mouse Neurons In Adherence(High magnification) |
|
![]() |
![]() |
| 2 days after electroporation The neurons were prepared from E15 mouse cerebral cortex. Electroporation: After 6 DIV (on 24-well plates) |
![]() ![]() |
| . | |
Primary Mouse Neurons In Adherence(High magnification) |
|
![]() |
![]() |
| 2 days after electroporation The neurons were prepared from E15 mouse cerebral cortex. Electroporation: After 6 DIV (on 24-well plates) |
![]() ![]() |
| . | |
Primary Mouse Hippocampal NeuronsIn Adherence |
|
![]() |
![]() |
Viability: 85% |
Transfection Efficiency: 54% |
| The neurons were prepared from E18 mouse cerebral cortex. Electroporation: After 2 DIV (on 24-well plates) |
![]() ![]() |
| . | |
Primary Mouse Glial cellsIn Adherence |
|
Electroporation: After 14 DIV |
![]() ![]() |
Viability: 80% |
Transfection Efficiency: 50% |




 - Human Embryonic Kidney cells – Viability 90 per cent.jpg)
 - Human Embryonic Kidney cells – Transfection Efficiency 90 per cent.jpg)



















































 - Human Trophoblast cells - Viability 95 per cent.jpg)
 - Human Trophoblast cells - Transfection Efficiency 67 per cent.jpg)






















 - Mouse Lewis lung cell carcinoma 1 cells - Viability 87 per cent.jpg)
 - Mouse Lewis lung cell carcinoma 1 cells - Transfection Efficiency 81 per cent.jpg)





























































































Electroporation: After 14 DIV